hair loss tirzepatide has increasingly been reported among patients using GLP-1 and GIP agonists for weight loss. These include drugs like semaglutide, tirzepatide, liraglutide and others. Historically, this hair loss has been attributed Another hair loss post :

Personal Opinion: For women who are candidates for HRT and seeking weight management, the combination with Retatrutide appears promising

Abstract Metabolic dysfunction-associated steatotic liver disease (MASLD) and its progressive inflammatory form, metabolic dysfunction-associated steatohepatitis (MASH), constitute an escalating worldwide health challenge, with prevalence estimates reaching one-quarter of adults globally

More recently, the SELECT trial evaluated overweight patients with CVD but without T2DM

Its essential to determine that there are no contraindications that would interfere with the safety or effectiveness of the treatment

Many patients reach their target weight and decide to put the finishing touches on their transformation with liposuction, a facelift, tummy tuck, or body contouring after weight loss